Literature DB >> 10638558

The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country.

A Rollan1, R Giancaspero, F Fuster, C Acevedo, C Figueroa, K Hola, M Schulz, I Duarte.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the effect of Helicobacter pylori (H. pylori) eradication on the natural history of duodenal ulcer disease and the reinfection rate after treatment in a developing country.
METHODS: A total of 111 H. pylori-infected patients with duodenal ulcer were treated with either omeprazole or famotidine plus two antibiotics for 2 wk. Those failed to respond to treatment were retreated with bismuth-based triple therapy.
RESULTS: The radication rate was 76% (95% CI: 67-83%). Eventually, H. pylori was eradicated in 96 of the 111 patients (86%), who were followed-up clinically and endoscopically for a mean of 37.2 months. The cumulative reinfection rate after eradication (Kaplan-Meier) was 8%+/-3% in yr 1, 11%+/-4% in yr 2, and 13%+/-4% in yr 3. Nine of the 12 reinfections occurred during yr 1. Recurrence of duodenal ulcer was detected in five patients (5.2%), all of them during yr 1 of follow-up. Histologically, gastritis scores (according to the Sydney system) improved significantly after eradication.
CONCLUSIONS: In a high prevalence setting, H. pylori eradication and early reinfection rates after treatment are similar to rates observed in a low prevalence environment, whereas the late reinfection rate seems to be higher. However, up to 3 yr after treatment, most treated patients are free of H. pylori infection and/or ulcer activity. Even longer follow-up studies are necessary to determine whether specific retreatment policies are necessary to maintain long term eradication in developing countries.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10638558     DOI: 10.1111/j.1572-0241.2000.01700.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  13 in total

1.  Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensus.

Authors:  Antonio Rollan; Juan Pablo Arab; M Constanza Camargo; Roberto Candia; Paul Harris; Catterina Ferreccio; Charles S Rabkin; Juan Cristóbal Gana; Pablo Cortés; Rolando Herrero; Luisa Durán; Apolinaria García; Claudio Toledo; Alberto Espino; Nicole Lustig; Alberto Sarfatis; Catalina Figueroa; Javier Torres; Arnoldo Riquelme
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Genotypic, clinical, and demographic characteristics of children infected with Helicobacter pylori.

Authors:  B D Gold; L J van Doorn; J Guarner; M Owens; D Pierce-Smith; Q Song; L Hutwagner; P M Sherman; O L de Mola; S J Czinn
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

Review 3.  Gastroenterology in developing countries: issues and advances.

Authors:  Kate L Mandeville; Justus Krabshuis; Nimzing Gwamzhi Ladep; Chris J J Mulder; Eamonn M M Quigley; Shahid A Khan
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

4.  Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities.

Authors:  Douglas R Morgan; Javier Torres; Rachael Sexton; Rolando Herrero; Eduardo Salazar-Martínez; E Robert Greenberg; Luis Eduardo Bravo; Ricardo L Dominguez; Catterina Ferreccio; Eduardo C Lazcano-Ponce; Maria Mercedes Meza-Montenegro; Edgar M Peña; Rodolfo Peña; Pelayo Correa; María Elena Martínez; William D Chey; Manuel Valdivieso; Garnet L Anderson; Gary E Goodman; John J Crowley; Laurence H Baker
Journal:  JAMA       Date:  2013-02-13       Impact factor: 56.272

5.  Reinfection rate and endoscopic changes after successful eradication of Helicobacter pylori.

Authors:  Kum Hei Ryu; Sun Young Yi; Youn Ju Na; Su Jung Baik; Su Jin Yoon; Hae-Sun Jung; Hyun Joo Song
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

6.  Construction of prokaryotic expression system of 2 148-bp fragment from cagA gene and detection of cagA gene, CagA protein in Helicobacter pylori isolates and its antibody in sera of patients.

Authors:  Jie Yan; Yuan Wang; Shi-He Shao; Ya-Fei Mao; Hua-Wen Li; Yi-Hui Luo
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

7.  Optimal length of triple therapy for H pylori eradication in a population with high prevalence of infection in Chile.

Authors:  Arnoldo Riquelme; Alejandro Soza; Cesar Pedreros; Andrea Bustamante; Felipe Valenzuela; Francisco Otarola; Eduardo Abbott; Marco Arellano; Brenda Medina; Alejandro Pattillo; Douglas Greig; Marco Arrese; Antonio Rollan
Journal:  World J Gastroenterol       Date:  2007-06-07       Impact factor: 5.742

8.  Low rate of recurrence of Helicobacter pylori infection in spite of high clarithromycin resistance in Pakistan.

Authors:  Javed Yakoob; Shahab Abid; Wasim Jafri; Zaigham Abbas; Khalid Mumtaz; Saeed Hamid; Rashida Ahmed
Journal:  BMC Gastroenterol       Date:  2013-02-21       Impact factor: 3.067

9.  Reinfection after successful eradication of Helicobacter pylori in three different populations in Alaska.

Authors:  M G Bruce; D L Bruden; J M Morris; A L Reasonover; F Sacco; D Hurlburt; T W Hennessy; J Gove; A Parkinson; G Sahagun; P Davis; J Klejka; B J McMahon
Journal:  Epidemiol Infect       Date:  2014-07-28       Impact factor: 4.434

10.  Helicobacter pylori related dyspepsia: prevalence and treatment outcomes at University Kebangsaan Malaysia-Primary Care Centre.

Authors:  Aznida Firzah Abdul Aziz; Zuhra Hamzah; Seng Fah Tong; Sukumar Nadeson; Sharifa Ezat Wan Puteh
Journal:  Asia Pac Fam Med       Date:  2009-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.